JP7022119B2 - 個人の生物学的ステータスを予測するためのシステム、方法および遺伝子シグネチャ - Google Patents
個人の生物学的ステータスを予測するためのシステム、方法および遺伝子シグネチャ Download PDFInfo
- Publication number
- JP7022119B2 JP7022119B2 JP2019513943A JP2019513943A JP7022119B2 JP 7022119 B2 JP7022119 B2 JP 7022119B2 JP 2019513943 A JP2019513943 A JP 2019513943A JP 2019513943 A JP2019513943 A JP 2019513943A JP 7022119 B2 JP7022119 B2 JP 7022119B2
- Authority
- JP
- Japan
- Prior art keywords
- gene
- genes
- status
- computer
- dataset
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 107
- 230000002068 genetic effect Effects 0.000 title description 26
- 108090000623 proteins and genes Proteins 0.000 claims description 176
- 230000004547 gene signature Effects 0.000 claims description 157
- 238000012360 testing method Methods 0.000 claims description 87
- -1 LINK00599 Proteins 0.000 claims description 77
- 230000014509 gene expression Effects 0.000 claims description 72
- 230000000391 smoking effect Effects 0.000 claims description 67
- 101000693721 Homo sapiens SAM and SH3 domain-containing protein 1 Proteins 0.000 claims description 45
- 102100025543 SAM and SH3 domain-containing protein 1 Human genes 0.000 claims description 45
- 101000986826 Homo sapiens P2Y purinoceptor 6 Proteins 0.000 claims description 44
- 102100028074 P2Y purinoceptor 6 Human genes 0.000 claims description 44
- 108010017222 Cyclin-Dependent Kinase Inhibitor p57 Proteins 0.000 claims description 39
- 102000004480 Cyclin-Dependent Kinase Inhibitor p57 Human genes 0.000 claims description 39
- 101001098529 Homo sapiens Proteinase-activated receptor 1 Proteins 0.000 claims description 38
- 102100037136 Proteinase-activated receptor 1 Human genes 0.000 claims description 38
- 101000609957 Homo sapiens PTB-containing, cubilin and LRP1-interacting protein Proteins 0.000 claims description 35
- 102100039157 PTB-containing, cubilin and LRP1-interacting protein Human genes 0.000 claims description 35
- 102100023416 G-protein coupled receptor 15 Human genes 0.000 claims description 34
- 101000829794 Homo sapiens G-protein coupled receptor 15 Proteins 0.000 claims description 34
- 101000654676 Homo sapiens Semaphorin-6B Proteins 0.000 claims description 32
- 102100032796 Semaphorin-6B Human genes 0.000 claims description 32
- 102100031725 Cortactin-binding protein 2 Human genes 0.000 claims description 30
- 101000941045 Homo sapiens Cortactin-binding protein 2 Proteins 0.000 claims description 30
- 102100026789 Aryl hydrocarbon receptor repressor Human genes 0.000 claims description 28
- 102100037709 Desmocollin-3 Human genes 0.000 claims description 28
- 101000968042 Homo sapiens Desmocollin-2 Proteins 0.000 claims description 28
- 101000880960 Homo sapiens Desmocollin-3 Proteins 0.000 claims description 28
- 102100032532 C-type lectin domain family 10 member A Human genes 0.000 claims description 27
- 101000942296 Homo sapiens C-type lectin domain family 10 member A Proteins 0.000 claims description 27
- 101000690533 Homo sapiens Aryl hydrocarbon receptor repressor Proteins 0.000 claims description 25
- 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 claims description 20
- 102100039357 Toll-like receptor 5 Human genes 0.000 claims description 20
- 101000709121 Homo sapiens Ral guanine nucleotide dissociation stimulator-like 1 Proteins 0.000 claims description 18
- 102100032665 Ral guanine nucleotide dissociation stimulator-like 1 Human genes 0.000 claims description 18
- 102100029378 Follistatin-related protein 1 Human genes 0.000 claims description 16
- 101001062535 Homo sapiens Follistatin-related protein 1 Proteins 0.000 claims description 16
- 230000008859 change Effects 0.000 claims description 16
- 102100025151 Adenylate kinase 8 Human genes 0.000 claims description 15
- 102100040754 Guanylate cyclase soluble subunit alpha-1 Human genes 0.000 claims description 15
- 101001077073 Homo sapiens Adenylate kinase 8 Proteins 0.000 claims description 15
- 101001038755 Homo sapiens Guanylate cyclase soluble subunit alpha-1 Proteins 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 15
- 102100037390 Genetic suppressor element 1 Human genes 0.000 claims description 14
- 101001026271 Homo sapiens Genetic suppressor element 1 Proteins 0.000 claims description 14
- 101000931590 Homo sapiens Prostaglandin F2 receptor negative regulator Proteins 0.000 claims description 14
- 101000796015 Homo sapiens Protein turtle homolog B Proteins 0.000 claims description 14
- 101000743488 Homo sapiens V-set and immunoglobulin domain-containing protein 4 Proteins 0.000 claims description 14
- 102100033256 Mitochondrial amidoxime reducing component 2 Human genes 0.000 claims description 14
- 101150010475 Mtarc2 gene Proteins 0.000 claims description 14
- 102100020864 Prostaglandin F2 receptor negative regulator Human genes 0.000 claims description 14
- 102100031337 Protein turtle homolog B Human genes 0.000 claims description 14
- 102100038296 V-set and immunoglobulin domain-containing protein 4 Human genes 0.000 claims description 14
- 101000710893 Homo sapiens Putative uncharacterized protein encoded by LINC02915 Proteins 0.000 claims description 12
- 102100033870 Putative uncharacterized protein encoded by LINC02915 Human genes 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 235000019505 tobacco product Nutrition 0.000 claims description 9
- 238000004590 computer program Methods 0.000 claims description 5
- 101000941865 Homo sapiens Leucine-rich repeat neuronal protein 3 Proteins 0.000 claims 4
- 102100032657 Leucine-rich repeat neuronal protein 3 Human genes 0.000 claims 4
- 101150059521 AHRR gene Proteins 0.000 claims 3
- 239000000523 sample Substances 0.000 description 92
- 239000008280 blood Substances 0.000 description 57
- 210000004369 blood Anatomy 0.000 description 56
- 238000012549 training Methods 0.000 description 45
- 238000010200 validation analysis Methods 0.000 description 34
- 238000004891 communication Methods 0.000 description 24
- 230000004044 response Effects 0.000 description 24
- 102000015981 Aryl hydrocarbon receptor repressor Human genes 0.000 description 20
- 108050004261 Aryl hydrocarbon receptor repressor Proteins 0.000 description 20
- 238000013145 classification model Methods 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- 101001069617 Homo sapiens Probable G-protein coupled receptor 63 Proteins 0.000 description 17
- 102100033862 Probable G-protein coupled receptor 63 Human genes 0.000 description 17
- 238000004458 analytical method Methods 0.000 description 16
- 241000894007 species Species 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 239000000779 smoke Substances 0.000 description 14
- 102100040739 Guanylate cyclase soluble subunit beta-1 Human genes 0.000 description 12
- 101001038731 Homo sapiens Guanylate cyclase soluble subunit beta-1 Proteins 0.000 description 12
- 238000009826 distribution Methods 0.000 description 12
- 230000008569 process Effects 0.000 description 11
- 230000005586 smoking cessation Effects 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 241000208125 Nicotiana Species 0.000 description 10
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 10
- 102100026293 Asialoglycoprotein receptor 2 Human genes 0.000 description 9
- 241000282412 Homo Species 0.000 description 9
- 101000785948 Homo sapiens Asialoglycoprotein receptor 2 Proteins 0.000 description 9
- 210000000601 blood cell Anatomy 0.000 description 9
- 238000010801 machine learning Methods 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 9
- 231100000027 toxicology Toxicity 0.000 description 9
- 102100032440 Beta-1,3-galactosyltransferase 2 Human genes 0.000 description 8
- 101000798387 Homo sapiens Beta-1,3-galactosyltransferase 2 Proteins 0.000 description 8
- 101000971533 Homo sapiens Killer cell lectin-like receptor subfamily G member 1 Proteins 0.000 description 8
- 102100021457 Killer cell lectin-like receptor subfamily G member 1 Human genes 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 102100031654 Cytochrome c oxidase subunit 6B2 Human genes 0.000 description 7
- 102100031132 Glucose-6-phosphate isomerase Human genes 0.000 description 7
- 108010070600 Glucose-6-phosphate isomerase Proteins 0.000 description 7
- 101000922370 Homo sapiens Cytochrome c oxidase subunit 6B2 Proteins 0.000 description 7
- 101001109700 Homo sapiens Nuclear receptor subfamily 4 group A member 1 Proteins 0.000 description 7
- 101001018109 Homo sapiens Nucleotidyltransferase MB21D2 Proteins 0.000 description 7
- 101000582950 Homo sapiens Platelet factor 4 Proteins 0.000 description 7
- 101000713602 Homo sapiens T-box transcription factor TBX21 Proteins 0.000 description 7
- 101000893741 Homo sapiens Tissue alpha-L-fucosidase Proteins 0.000 description 7
- 101000909110 Homo sapiens Ultra-long-chain fatty acid omega-hydroxylase Proteins 0.000 description 7
- 102100022679 Nuclear receptor subfamily 4 group A member 1 Human genes 0.000 description 7
- 102100033052 Nucleotidyltransferase MB21D2 Human genes 0.000 description 7
- 102100030304 Platelet factor 4 Human genes 0.000 description 7
- 102100036840 T-box transcription factor TBX21 Human genes 0.000 description 7
- 102100040526 Tissue alpha-L-fucosidase Human genes 0.000 description 7
- 102100024915 Ultra-long-chain fatty acid omega-hydroxylase Human genes 0.000 description 7
- 238000013500 data storage Methods 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 101000933252 Homo sapiens Protein BEX3 Proteins 0.000 description 6
- 101001106082 Homo sapiens Receptor expression-enhancing protein 6 Proteins 0.000 description 6
- 101000679406 Homo sapiens Tubulin polymerization-promoting protein family member 3 Proteins 0.000 description 6
- 102100025955 Protein BEX3 Human genes 0.000 description 6
- 102100021075 Receptor expression-enhancing protein 6 Human genes 0.000 description 6
- 102100022567 Tubulin polymerization-promoting protein family member 3 Human genes 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000007477 logistic regression Methods 0.000 description 6
- 238000007637 random forest analysis Methods 0.000 description 6
- 238000012552 review Methods 0.000 description 6
- 102100027634 Fibronectin type 3 and ankyrin repeat domains protein 1 Human genes 0.000 description 5
- 101000937169 Homo sapiens Fibronectin type 3 and ankyrin repeat domains protein 1 Proteins 0.000 description 5
- 101001098232 Homo sapiens P2Y purinoceptor 1 Proteins 0.000 description 5
- 101000579300 Homo sapiens Prostaglandin F2-alpha receptor Proteins 0.000 description 5
- 101000818706 Homo sapiens Zinc finger protein 618 Proteins 0.000 description 5
- 102100037600 P2Y purinoceptor 1 Human genes 0.000 description 5
- 102100028248 Prostaglandin F2-alpha receptor Human genes 0.000 description 5
- 102100021103 Zinc finger protein 618 Human genes 0.000 description 5
- 238000003491 array Methods 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 102100031969 Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 Human genes 0.000 description 4
- 101000703728 Homo sapiens Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 Proteins 0.000 description 4
- 101000707218 Homo sapiens SH2 domain-containing protein 1B Proteins 0.000 description 4
- 101000645402 Homo sapiens Transmembrane protein 163 Proteins 0.000 description 4
- 241000283984 Rodentia Species 0.000 description 4
- 102100031778 SH2 domain-containing protein 1B Human genes 0.000 description 4
- 102100025764 Transmembrane protein 163 Human genes 0.000 description 4
- 238000000205 computational method Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000013507 mapping Methods 0.000 description 4
- 238000001790 Welch's t-test Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000002493 microarray Methods 0.000 description 3
- 238000012502 risk assessment Methods 0.000 description 3
- 238000012358 sourcing Methods 0.000 description 3
- 238000012706 support-vector machine Methods 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 101150078635 18 gene Proteins 0.000 description 2
- 102000013918 Apolipoproteins E Human genes 0.000 description 2
- 108010025628 Apolipoproteins E Proteins 0.000 description 2
- 230000007067 DNA methylation Effects 0.000 description 2
- 101100100081 Oryza sativa subsp. japonica TPP3 gene Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000004931 aggregating effect Effects 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000002790 cross-validation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- 101150000874 11 gene Proteins 0.000 description 1
- 102100021580 Active regulator of SIRT1 Human genes 0.000 description 1
- 102100032249 Dystonin Human genes 0.000 description 1
- 101001016186 Homo sapiens Dystonin Proteins 0.000 description 1
- 101000840258 Homo sapiens Immunoglobulin J chain Proteins 0.000 description 1
- 101000959664 Homo sapiens Interferon-induced protein 44-like Proteins 0.000 description 1
- 101000966782 Homo sapiens Lysophosphatidic acid receptor 1 Proteins 0.000 description 1
- 101000735213 Homo sapiens Palladin Proteins 0.000 description 1
- 101000874141 Homo sapiens Probable ATP-dependent RNA helicase DDX43 Proteins 0.000 description 1
- 101000801255 Homo sapiens Tumor necrosis factor receptor superfamily member 17 Proteins 0.000 description 1
- 102100029571 Immunoglobulin J chain Human genes 0.000 description 1
- 102100039953 Interferon-induced protein 44-like Human genes 0.000 description 1
- 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 description 1
- 102100040607 Lysophosphatidic acid receptor 1 Human genes 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 101100055876 Mus musculus Apoe gene Proteins 0.000 description 1
- 101100136626 Oryza sativa subsp. japonica PHT1-6 gene Proteins 0.000 description 1
- 102100035031 Palladin Human genes 0.000 description 1
- 102100035724 Probable ATP-dependent RNA helicase DDX43 Human genes 0.000 description 1
- 108090001010 Protease-activated receptor 4 Proteins 0.000 description 1
- 239000013614 RNA sample Substances 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- 101150026963 RPS19BP1 gene Proteins 0.000 description 1
- 101000832669 Rattus norvegicus Probable alcohol sulfotransferase Proteins 0.000 description 1
- 101100495267 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CDC25 gene Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 102100033726 Tumor necrosis factor receptor superfamily member 17 Human genes 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000809 air pollutant Substances 0.000 description 1
- 231100001243 air pollutant Toxicity 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000013502 data validation Methods 0.000 description 1
- 238000003066 decision tree Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000004049 epigenetic modification Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000010305 frozen robust multiarray analysis Methods 0.000 description 1
- 230000004077 genetic alteration Effects 0.000 description 1
- 231100000118 genetic alteration Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000002952 image-based readout Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 231100000037 inhalation toxicity test Toxicity 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000004901 leucine-rich repeat Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 230000005486 microgravity Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007427 paired t-test Methods 0.000 description 1
- 238000010239 partial least squares discriminant analysis Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108010026311 purinoceptor P2Y6 Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000011222 transcriptome analysis Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 230000002034 xenobiotic effect Effects 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Bioethics (AREA)
- Evolutionary Computation (AREA)
- Artificial Intelligence (AREA)
- Software Systems (AREA)
- Primary Health Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022016224A JP7275334B2 (ja) | 2016-09-14 | 2022-02-04 | 個人の生物学的ステータスを予測するためのシステム、方法および遺伝子シグネチャ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662394551P | 2016-09-14 | 2016-09-14 | |
| US62/394,551 | 2016-09-14 | ||
| PCT/EP2017/063073 WO2018050299A1 (en) | 2016-09-14 | 2017-05-30 | Systems, methods, and gene signatures for predicting a biological status of an individual |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022016224A Division JP7275334B2 (ja) | 2016-09-14 | 2022-02-04 | 個人の生物学的ステータスを予測するためのシステム、方法および遺伝子シグネチャ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019532410A JP2019532410A (ja) | 2019-11-07 |
| JP2019532410A5 JP2019532410A5 (enExample) | 2020-07-16 |
| JP7022119B2 true JP7022119B2 (ja) | 2022-02-17 |
Family
ID=59021473
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019513943A Active JP7022119B2 (ja) | 2016-09-14 | 2017-05-30 | 個人の生物学的ステータスを予測するためのシステム、方法および遺伝子シグネチャ |
| JP2022016224A Active JP7275334B2 (ja) | 2016-09-14 | 2022-02-04 | 個人の生物学的ステータスを予測するためのシステム、方法および遺伝子シグネチャ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022016224A Active JP7275334B2 (ja) | 2016-09-14 | 2022-02-04 | 個人の生物学的ステータスを予測するためのシステム、方法および遺伝子シグネチャ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190244677A1 (enExample) |
| EP (1) | EP3513344A1 (enExample) |
| JP (2) | JP7022119B2 (enExample) |
| KR (2) | KR102421109B1 (enExample) |
| CN (1) | CN109643584A (enExample) |
| CA (1) | CA3036597C (enExample) |
| MX (1) | MX2019002316A (enExample) |
| WO (1) | WO2018050299A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102517328B1 (ko) * | 2021-03-31 | 2023-04-04 | 주식회사 크라우드웍스 | 작업툴을 이용한 이미지 내 세포 분별에 관한 작업 수행 방법 및 프로그램 |
| CN113159571B (zh) * | 2021-04-20 | 2024-08-27 | 中国农业大学 | 一种跨境外来物种风险等级判定及智能识别方法及系统 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006314315A (ja) | 2005-05-10 | 2006-11-24 | Synergenz Bioscience Ltd | 肺の機能と異常を調べるための方法と組成物 |
| JP2011516046A (ja) | 2008-03-28 | 2011-05-26 | トラスティーズ オブ ボストン ユニバーシティ | 肺障害の検出のための多元的方法 |
| JP2012518997A (ja) | 2009-02-26 | 2012-08-23 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 喫煙未経験者におけるマイクロrna、ならびに関連する材料および方法 |
| JP2014531202A (ja) | 2011-08-29 | 2014-11-27 | カーディオ ディーエクス インコーポレイティッド | 喫煙状態を判定するための方法および組成物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005000098A2 (en) * | 2003-06-10 | 2005-01-06 | The Trustees Of Boston University | Detection methods for disorders of the lung |
| EP2605018A1 (en) * | 2006-03-09 | 2013-06-19 | The Trustees of the Boston University | Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells |
| GB2512153B (en) * | 2008-11-17 | 2014-11-12 | Veracyte Inc | Methods and compositions of molecular profiling for disease diagnostics |
| US20120245952A1 (en) * | 2011-03-23 | 2012-09-27 | University Of Rochester | Crowdsourcing medical expertise |
| WO2014039859A1 (en) * | 2012-09-06 | 2014-03-13 | Duke University | Diagnostic markers for platelet function and methods of use |
| JP6703479B2 (ja) * | 2013-12-16 | 2020-06-03 | フィリップ モリス プロダクツ エス アー | 個人の喫煙ステータスを予測するためのシステムおよび方法 |
| WO2016011068A1 (en) * | 2014-07-14 | 2016-01-21 | Allegro Diagnostics Corp. | Methods for evaluating lung cancer status |
| EP3770274A1 (en) * | 2014-11-05 | 2021-01-27 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
-
2017
- 2017-05-30 KR KR1020197009475A patent/KR102421109B1/ko active Active
- 2017-05-30 MX MX2019002316A patent/MX2019002316A/es unknown
- 2017-05-30 US US16/333,157 patent/US20190244677A1/en not_active Abandoned
- 2017-05-30 WO PCT/EP2017/063073 patent/WO2018050299A1/en not_active Ceased
- 2017-05-30 CA CA3036597A patent/CA3036597C/en active Active
- 2017-05-30 KR KR1020227023834A patent/KR102685289B1/ko active Active
- 2017-05-30 JP JP2019513943A patent/JP7022119B2/ja active Active
- 2017-05-30 EP EP17728486.6A patent/EP3513344A1/en active Pending
- 2017-05-30 CN CN201780050613.8A patent/CN109643584A/zh active Pending
-
2022
- 2022-02-04 JP JP2022016224A patent/JP7275334B2/ja active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006314315A (ja) | 2005-05-10 | 2006-11-24 | Synergenz Bioscience Ltd | 肺の機能と異常を調べるための方法と組成物 |
| JP2011516046A (ja) | 2008-03-28 | 2011-05-26 | トラスティーズ オブ ボストン ユニバーシティ | 肺障害の検出のための多元的方法 |
| JP2012518997A (ja) | 2009-02-26 | 2012-08-23 | ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション | 喫煙未経験者におけるマイクロrna、ならびに関連する材料および方法 |
| JP2014531202A (ja) | 2011-08-29 | 2014-11-27 | カーディオ ディーエクス インコーポレイティッド | 喫煙状態を判定するための方法および組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2019002316A (es) | 2019-06-24 |
| KR102421109B1 (ko) | 2022-07-14 |
| CA3036597A1 (en) | 2018-03-22 |
| JP2019532410A (ja) | 2019-11-07 |
| KR20190046940A (ko) | 2019-05-07 |
| KR20220103819A (ko) | 2022-07-22 |
| EP3513344A1 (en) | 2019-07-24 |
| JP2022062189A (ja) | 2022-04-19 |
| JP7275334B2 (ja) | 2023-05-17 |
| BR112019004920A2 (pt) | 2019-06-04 |
| US20190244677A1 (en) | 2019-08-08 |
| CN109643584A (zh) | 2019-04-16 |
| WO2018050299A1 (en) | 2018-03-22 |
| CA3036597C (en) | 2023-03-28 |
| KR102685289B1 (ko) | 2024-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Whalen et al. | Navigating the pitfalls of applying machine learning in genomics | |
| Ng et al. | The benefits and pitfalls of machine learning for biomarker discovery | |
| Chung et al. | Decoding the exposome: data science methodologies and implications in exposome-wide association studies (ExWASs) | |
| US10339464B2 (en) | Systems and methods for generating biomarker signatures with integrated bias correction and class prediction | |
| US10373708B2 (en) | Systems and methods for generating biomarker signatures with integrated dual ensemble and generalized simulated annealing techniques | |
| JP6138793B2 (ja) | ネットワークに基づく生物学的活性評価のためのシステムおよび方法 | |
| Maguluri et al. | Big Data Solutions For Mapping Genetic Markers Associated With Lifestyle Diseases | |
| CA2877436C (en) | Systems and methods for generating biomarker signatures | |
| Kumar et al. | Metabolomic biomarker identification in presence of outliers and missing values | |
| Zheng et al. | Comparison of pathway and gene-level models for cancer prognosis prediction | |
| JP7275334B2 (ja) | 個人の生物学的ステータスを予測するためのシステム、方法および遺伝子シグネチャ | |
| Rao et al. | Essential statistical methods for medical statistics | |
| KR101067352B1 (ko) | 생물학적 네트워크 분석을 이용한 마이크로어레이 실험 자료의 작용기작, 실험/처리 조건 특이적 네트워크 생성 및 실험/처리 조건 관계성 해석을 위한 알고리즘을 포함한 시스템 및 방법과 상기 방법을 수행하기 위한 프로그램을 갖는 기록매체 | |
| Belcastro et al. | The sbv IMPROVER systems toxicology computational challenge: identification of human and species-independent blood response markers as predictors of smoking exposure and cessation status | |
| Deng et al. | Introduction to the development and validation of predictive biomarker models from high-throughput data sets | |
| BR112019004920B1 (pt) | Método implementado por computador para prever o status de fumo de um indivíduo e kit para prever o status de fumo de um indivíduo | |
| Rekaya et al. | Misclassification in binary responses and effect on genome-wide association studies | |
| Belcastro et al. | Computational Toxicology | |
| Gibbs et al. | Case studies in data analysis | |
| HK1209202B (en) | Systems and methods for generating biomarker signatures |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20190405 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20190410 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200601 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200601 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210818 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211112 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220106 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220204 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7022119 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |